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Feline inflammatory lower airway disease is a frequently 
encountered disease complex in cats. Although a com-
mon clinical problem, the condition has been poorly 
defined.1 Based upon the type of inflammatory response, 
two main disease forms have been described in cats: 
chronic bronchitis (CB) and feline asthma (FA).2 While 
CB describes a neutrophilic inflammation of the lower 
airways accompanied by oedema and hypertrophy of 
the respiratory mucosa and excessive mucus production, 
FA represents a T cell-induced hypersensitivity reaction 
characterised by eosinophilic airway inflammation and 
bronchoconstriction.1 Similar to the main triggers known 
for human asthma, various possible aetiologies have 
also been discussed for feline inflammatory airway dis-
ease, including drugs, environmental substances and 
toxins, exercise, stress, allergens and infections.3
Mycoplasma species are small bacteria lacking a pepti-
doglycan cell wall.4 Belonging to the normal commensal 
flora of the upper airways in cats,5,6 the organisms have 
also been detected in cases with conjunctivitis, upper 
respiratory infection7–9 and lower respiratory tract infec-
tion in this species10–13; however, they also have been 
detected in cats with inflammatory bronchial 
disease.14,15
In humans, infections with Mycoplasma pneumoniae 
have recently been linked to asthma.16 M pneumoniae is 
known to represent an important aetiological pathogen 
for childhood pneumonia.17 Infections with the organism 
can precede the onset of asthma, exacerbate asthmatic 
Detection of feline Mycoplasma 
species in cats with feline asthma 
and chronic bronchitis
Bianka S Schulz, Petra Richter, Karin Weber, Ralf S Mueller, 
Gerhard Wess, Isabella Zenker and Katrin Hartmann
Abstract
Little is known about the aetiology of inflammatory lower airway disease in cats. The aim of this study was to 
investigate the role of Mycoplasma species in cats with feline asthma (FA) and chronic bronchitis (CB). The study 
population consisted of 17 cats with FA/CB, and 14 sick cats without clinical and historical signs of respiratory 
disease, which were euthanased for various other reasons. Nasal swabs, nasal lavage and bronchoalveolar lavage 
fluid (BALF) samples were taken from patients from both groups. Mycoplasma species culture with modified Hayflick 
agar and Mycoplasma polymerase chain reaction (PCR) were performed on all samples followed by sequencing of 
all Mycoplasma species-positive samples for differentiation of subspecies. PCR testing detected significantly more 
Mycoplasma species-positive BALF samples than Mycoplasma culture (P = 0.021). When cats with oropharyngeal 
contamination were excluded from comparison, the numbers of Mycoplasma species-positive BALF samples in 
the group with FA/CB (6/17) and the control group (4/9) were not significantly different (P = 0.6924). While all 
nasal samples of the cats with FA/CB were negative for Mycoplasma organisms, five samples in the control group 
(P = 0.041) were positive on PCR. Sequencing revealed Mycoplasma felis in all PCR-positive samples. Mycoplasma 
species can be detected in the lower airways of cats with FA/CB, as well as in the BALF of sick cats without 
respiratory signs. Further studies are warranted to investigate the possibility that Mycoplasma species represent 
commensals of the lower respiratory tract of cats.
Accepted: 27 January 2014
Clinic of Small Animal Medicine, Ludwig Maximilian University  
of Munich, Munich, Germany
Corresponding author:
Bianka Schulz Dr Med Vet, Dipl ECVIM-CA (Internal Medicine), 
Clinic of Small Animal Medicine, Ludwig Maximilian University  
of Munich, Veterinaerstrasse 13, 80539 Munich, Germany
Email: b.schulz@medizinische-kleintierklinik.de
524969 JFM0010.1177/1098612X14524969Journal of Feline Medicine and SurgerySchulz et al
research-article2014
Original Article
944 Journal of Feline Medicine and Surgery 16(12)
signs and cause difficulties in asthma management.16 
Furthermore, M pneumoniae infection has been signifi-
cantly associated with acute exacerbation of asthma.18 
Antibiotic treatment resulted in improvement of lung 
function in asthmatic patients who were polymerase 
chain reaction (PCR)-positive for M pneumoniae in their 
lower airways.19 Several pathophysiological mechanisms 
have been discussed for how Mycoplasma species infec-
tions might trigger chronic bronchial disease. In the early 
phase of infection, Mycoplasma organisms interact with 
respiratory epithelial cells, leading to multifactorial alter-
ations. Mycoplasma pneumoniae infection in children with 
wheezing episodes has been seen to induce an increase in 
the production of interleukin-5, a cytokine promoting 
eosinophilic airway inflammation and the development 
of airway hyperresponsiveness.20
The aim of this study was to investigate the role of 
Mycoplasma species in cats with FA and CB, and to com-
pare the data with results from cats without clinical or 
historical signs of respiratory tract disease.
Materials and methods
Study design and animals
The prospective study was conducted between May 
2009 and April 2011 with informed owner consent 
obtained for all patients. Seventeen cats diagnosed with 
FA/CB, and 14 sick cats without clinical and historical 
signs of respiratory tract disease were included in the 
study. All 31 cats were patients presented to the Clinic of 
Small Animal Medicine of the Ludwig Maximilian 
University of Munich, Germany.
Inclusion criteria for cats with FA/CB were a history 
of clinical signs typical for this disease complex, includ-
ing cough, tachypnoea, wheezing or episodes of dysp-
noea, and a positive response to treatment with inhaled 
or systemic steroids. Cytology of bronchoalveolar lavage 
fluid (BALF) had to show increased numbers of eosino-
phils, mature neutrophils or a mixed eosinophilic/neu-
trophilic inflammatory pattern. Cats with a physiological 
cytology and with low numbers of physiological cells on 
BALF were included if clinical signs were typical for FA/
CB, differentials had been excluded during diagnostic 
work-up and if they showed a long-term response to 
steroid treatment. Patients were excluded if they were 
diagnosed with heart failure, neoplasia, pleural effusion, 
pneumonia or other diseases of the respiratory tract 
except for FA/CB, or if they were infected with feline 
leukaemia virus (FeLV) or feline immunodeficiency 
virus (FIV). To confirm the diagnosis of FA/CB, to 
exclude other diseases and to obtain sample material for 
Mycoplasma species detection, several diagnostic tests 
were performed in all 17 cats: standardised physical 
examination, haematology, echocardiogram, thoracic 
radiographs in two views (right-lateral and ventrodor-
sal), Baermann faecal examination to rule out lungworm 
infection, and bronchoalveolar lavage (BAL) with cyto-
logical examination and bacterial culture of the BALF. A 
serum sample of all cats with FA/CB was tested for FIV 
antibodies and FeLV antigen (Snap Combo Plus Test; 
Idexx Laboratories).
Cats in the control group were euthanased for other 
reasons than respiratory or cardiac problems. They were 
included if they did not have a history of respiratory dis-
ease within the last 6 months and if physical examina-
tion of the respiratory tract was unremarkable. Reasons 
for euthanasia in the control group were lymphoma (n = 
4), seizures (n = 2), pancytopenia (n = 2), neoplasia of the 
pancreas (n = 1), chronic renal disease (n = 1), peritonitis 
(n = 1), hyperthyroidism (n = 1), non-regenerative anae-
mia (n = 1) and diabetic ketoacidosis (n = 1).
Sample collection
Faecal samples of all cats of the FA/CB group were col-
lected for three consecutive days for Baermann faecal 
examinaton and analysed according to a standardised 
protocol.21
To obtain BALF, cats of the FA/CB group were pre-
medicated with atropine (Atropinsulfat, 0.5 mg/ml IV; 
B Braun) and midazolam (Midazolam-ratiopharm, 0.2 
mg/kg IV; Ratiopharm) followed by propofol anaesthe-
sia (Narcofol, 6–8 mg/kg IV; CP-Pharma 
Handelsgesellschaft). Cats were placed in a sternal posi-
tion, intubated with a sterile autoclaved endotracheal 
tube and pre-oxygenated for 3–5 mins. A sterile catheter 
(CH 4.5, 1.0 × 1.5; B Braun Vet Care) was inserted into the 
endotracheal tube and gently forwarded into the lower 
airways until resistance was noticed. The lavage was 
performed by applying 3 ml of sterile sodium chloride 
solution (Isotone Kochsalz-Lösung, 0.9%; B Braun Vet 
Care) through the catheter followed by recovery of the 
fluid with a sterile collection container (Lukens 
Schleimprobenbehälter; Olympus) that interconnected 
the catheter and the mechanical suction apparatus. The 
blind lavage procedure was repeated 1–2 times in one 
area until at least 1 ml of BALF was recovered. In all 14 
cats in the control group, BAL was performed within 5 
mins of euthanasia. The procedure was carried out as 
described above, except for the fact that BALF was 
recovered by manual suction with a syringe.
Diagnostic tests performed on BALF samples of all 
31 cats included cytology, bacterial culture, Mycoplasma 
species culture and PCR for Mycoplasma species 
detection. In all PCR-positive samples, sequencing was 
conducted to determine the Mycoplasma species 
involved.
Sterile nasal swabs (sterile swab with Amies transport 
medium; Sarstedt) were taken from 12 cats with FA/CB 
and from 12 control cats after the BAL. Nasal lavage was 
performed in 13 cats with FA/CB and in 14 cats in the 
control group after the BAL with 3 ml of sterile sodium 
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chloride solution (Isotone Kochsalz-Lösung, 0.9%; B 
Braun Vet Care). Nasal swabs were submitted for 
Mycoplasma species culture, while nasal flush samples 
were used for DNA extraction and Mycoplasma PCR. 
Sequencing was performed in all PCR-positive samples 
to determine the Mycoplasma species.
BALF cytology
All cytology samples were evaluated by the same person 
(IZ). Cytocentrifuge-concentrated smears (5 mins at 
95 g) were prepared immediately after collection and 
stained with modified Wright’s stain after air drying. 
Cytological evaluation was performed with a light opti-
cal microscope (Olympus BX 51; Olympus Deutschland) 
following a standardised protocol. The slide with the 
best quality was chosen and 500 inflammatory cells per 
slide were counted (5 × 100 cells on different areas of the 
slide). The predominating cell type was documented 
based upon reference values previously established for 
interpretation of feline BALF cytology.22,23 An eosino-
philic inflammation was diagnosed if BALF cytology 
revealed >20% of eosinophils; a diagnosis of CB was 
established if >7% non-degenerative neutrophils were 
present. Samples with >20% eosinophils and >7% neu-
trophils were classified as mixed eosinophilic/neutro-
philic inflammation. Samples with macrophages as the 
predominating cell type, <20% eosinophils and <7% 
neutrophils were classified as physiological. A standard-
ised search for microorganisms was performed (100 
fields with 100-fold magnification). Simonsiella species 
organisms and squamous cells on cytology were inter-
preted as oropharyngeal contamination. Samples classi-
fied as oropharyngeal contamination were samples 
displaying Simonsiella species organisms and squamous 
cells with an otherwise physiological cell population. 
Samples were classified as low cellularity if they con-
tained only a few physiological cells, but were too dilute 
to perform a standardised cell count.
Bacterial cultures
Bacterial and Mycoplasma species cultures were per-
formed at the Institute for Infectious Diseases and 
Zoonoses of the Ludwig Maximilian University of 
Munich, Germany. For bacterial culture, 50 µl BALF was 
applied to an agar plate. Test systems used for the detec-
tion of aerobic and anaerobic bacteria included Gassner 
and Rambach agar, sheep blood agar with colistin and 
nalidixin acid, and Bordet–Gengou agar for selective cul-
ture of Bordetella bronchiseptica. After inoculation, agar 
plates were incubated at 37°C for 48 h.
For Mycoplasma species culture, nasal swabs were first 
streaked onto a modified Hayflick agar and then rotated 
in a Hayflick bouillon in which the swab remained. 
BALF samples were applied to the Hayflick agar and to 
the bouillon. Fifty microlitres of sample fluid was 
applied to the agar plate and 50 µl was added to 3 ml of 
bouillon. Plates and bouillon were incubated under car-
bon dioxide nebulisation for 10 days, and then a gas 
pack (Anaerocult C for microbiology; Merck) humidified 
with 6 ml water was added before samples were incu-
bated in an incubator at 37°C. Evaluation of plates and 
bouillon for Mycoplasma species colonies was performed 
on days 2, 4, 7 and 10 with a stereomicroscope.
PCR
DNA extraction was performed using the DNeasy Blood 
and Tissue Kit (Qiagen). The BALF samples were 
extracted using an adapted protocol for viscous samples. 
Briefly, the BALF sample (1–2 ml) was mixed with 30 µl 
acetylcystein solution (100 mg/ml) and vortexed to 
reduce viscosity. The sample was pelleted by centrifuga-
tion and re-suspended in 1 ml phosphate-buffered saline 
(PBS). The sample was centrifuged again and the cell 
pellet was re-suspended in 200 µl PBS. Nasal flush sam-
ples were also centrifuged and the cell pellet was re-sus-
pended in 200 µl PBS. DNA extraction was performed 
according to the manufacturer’s instructions. The DNA 
was eluted in 100 µl elution buffer and stored at −20°C. 
For the PCR, feline 28s recombinant DNA was amplified 
in each sample to confirm successful DNA extraction. 
The primer pair feline-28s-F (forward primer) and feline-
28s-R (reverse primer) (Table 1) was mixed with Hot Star 
Taq Mastermix (Qiagen), and the DNA extracted from 
BALF and nasal flush sample. Amplification was done 
on an Eppendorf Mastercycler for 30 cycles with an 
annealing temperature of 60°C. For Mycoplama species 
detection, the primer pair Mycopl16sF (forward primer) 
and Mycopl16sR (reverse primer) (Table 2) was used, 
which is able to amplify, among others, Mycoplasma 
arthridis, Mycoplasma canadense, Mycoplasma cynos, 
Mycoplasma felis, Mycoplasma gateae, Mycoplasma hyophar-
yngis and Mycoplasma lipophilum. DNA samples were 
mixed with primers and the Hot Star Taq Mastermix, 
and PCR products were amplified for 30 cycles with an 
annealing temperature of 58°C, as described above.
Sequence analysis
PCR products were purified using the QIAquick PCR 
Purification Kit (Qiagen), according to the manufactur-
er’s instructions. The cleaned samples were mixed with 
Mycopl16sF as the sequencing primer and sequenced by 
Eurofins MWG Operon. The sequence identities were 
determined using BLAST.
Statistical evaluation
Statistical evaluation was performed with the software 
GraphPad Prism Version 5.00 (GraphPad Software). The 
Kolmogorov–Smirnov and D’Agostino tests were used 
to test for parametric distribution of numeric data. Data 
comparison of normally distributed data was performed 
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with a non-paired t-test. The Mann–Whitney test was 
used for data not normally distributed. Ratios were eval-
uated with Fisher’s exact test. The level of significance 
was set at <0.05 for all comparisons.
Results
Study population
The median age of cats with FA/CB was 8.0 years (mean 
6.4 years) and the median age of the control cats was 12.0 
years (mean 13.2 years); this difference was not signifi-
cant (P = 0.662). The cats with FA/CB included seven 
male castrated, one intact male and nine female spayed 
cats; the control group consisted of six male castrated 
and eight female spayed cats. Breed distribution in the 
FA/CB group included 15 domestic shorthair (DSH) 
cats, one British Shorthair and one Persian mix. The con-
trol group consisted of 11 DSH, one Devon Rex, one 
Maine Coon and one Persian mix. Clinical signs of the 
cats with FA/CB included cough (14/17), tachypnoea 
(2/17) and dyspnoea (1/17).
Cytological examination of BALF samples
While cats with FA/CB more often showed an eosino-
philic and eosinophilic/neutrophilic inflammation, 
cats from the control group were more often diag-
nosed with oropharyngeal contamination of the BALF 
(Table 3).
Detection of Mycoplasma species
Significantly more Mycoplasma species-positive samples 
were detected by PCR in the nasal flush samples of control 
cats than those of the FA/CB group (Table 4). No significant 
difference could be detected when Mycoplasma species 
PCR-positive BALF samples were compared between both 
groups. There was also no significant difference between 
groups regarding Mycoplasma species PCR-positive BALF 
samples when cats with oropharyngeal contamination 
were excluded from comparison and Mycoplasma species-
positive BALF samples of cats with FA/CB (6/17) and con-
trols (4/9) were compared (P = 0.6924). Furthermore, there 
was no significant difference between the groups when all 
cats showing oropharyngeal contamination, samples with 
low cellularity and the two cats in the FA/CB group with a 
physiological BALF cytology were excluded from the com-
parison (P = 1.000). Culture results of Mycoplasma species-
positive nasal and BALF samples were not significantly 
different between groups.
Comparison of PCR and culture
In nasal flush samples, there was no significant differ-
ence between number of PCR-positive (5/27) and cul-
ture-positive (2/24) samples of all cats (P = 0.425). In 
contrast, BALF samples were significantly more often 
PCR-positive (13/31) than culture-positive (4/31) 
(P = 0.021).
Sequencing of Mycoplasma species-positive 
samples
Sequencing was performed in all Mycoplasma species 
PCR-positive samples. In all 18 samples, M felis was 
identified as the only species.
Discussion
Detection of Mycoplasma species in the lower respiratory 
tract of cats has been linked to pneumonia in several stud-
ies.10–13 As Mycoplasma organisms have not so far been 
found in the lower airways of healthy cats, it has been dis-
cussed whether they represent primary respiratory patho-
gens in the cat, rather than opportunistic invaders.6,22 
Mycoplasma species have also been isolated from cats with 
inflammatory bronchial disease and discussed as a poten-
tial trigger for FA or CB.14,15,24 In this study, Mycoplasma 
species were detected in the BALF of cats with FA/CB, as 
well as in samples from cats without clinical respiratory 
abnormalities. However, samples in the control group 
were taken shortly after euthanasia and 5/14 obtained 
BALF samples showed oropharyngeal contamination on 
cytology, while in the FA/CB group none of the 17 sam-
ples was contaminated with oropharyngeal material. One 
explanation for this finding could be the fact that the cri-
copharyngeal muscles relax post mortem, which might 
facilitate draining of saliva into the lower airways, leading 
to oropharyngeal contamination with Simonsiellea species 
and squamous cells. However, when cats with oropharyn-
geal contamination were excluded from the statistical 
evaluation, the remaining Mycoplasma species-positive 
BALF samples of cats with FA/CB and controls were still 
not different. However, it could also be possible that post-
mortem oropharyngeal contamination occurred in even 
more cats than only in the ones detected by light micros-
copy, and that numbers of squamous epithelial cells and 
Simonsiella organisms were too low for detection in some 
cats. Quantitative real-time PCR for the detection of 
Mycoplasma species could have been helpful to further 
investigate this possibility and to differentiate between 
Table 1 Nucleotide sequences of feline 28s forward and 




Table 2 Nucleotide sequences of Mycopl16sF forward 
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cats with low and high numbers of Mycoplasma 
organisms.
In the group of cats with FA/CB, two cats with a physi-
ological cell pattern and one cat with low numbers of cells 
on BALF cytology were also included; three cats with sam-
ples of low cellularity were included in the control group. 
The reason for the inclusion of these patients in the FA/CB 
group was that all three cats showed typical signs consist-
ent with a diagnosis of FA/CB (chronic cough), other res-
piratory diseases could not be detected on diagnostic 
work-up and they responded well to steroid treatment. In 
addition, two of the three cats showed eosinophilia on 
blood work. To investigate the possibility that results might 
have been influenced by the inclusion of insufficiently clas-
sified BALF samples, comparison was repeated excluding 
the physiological cytology samples of the cats with FA/CB 
and all samples with low cellularity and oropharyngeal 
contamination, which still resulted in no difference between 
groups. However, the results have to be interpreted with 
caution, as the sample size for this comparison was small.
Mycoplasma species were detected by PCR in more 
than a third of nasal samples from control cats without 
respiratory signs. Similar to the findings of this study, 
Mycoplasma species have been previously cultured from 
the upper airways of cats with respiratory tract infec-
tion7,8 and the upper respiratory tract of healthy cats,5,6 
indicating a role as a commensal organism in the upper 
airways of cats. In contrast to detection in the lower air-
ways, Mycoplasma species were only detected in nasal 
samples of control cats, but not in samples of cats with 
FA/CB in this study. All control cats were assessed as res-
piratory healthy by history, clinical examination and 
BALF diagnostics; however, these animals suffered from 
other severe diseases and some had received immuno-
suppressive therapy prior to euthanasia, potentially 
influencing the growth of Mycoplasma species because of 
systemic immunosuppression. In contrast to that, most 
cats in the FA/CB group had not been pretreated with 
steroids or other immunosuppressive agents, potentially 
explaining the difference between both groups regarding 
the recovery of Mycoplasma organisms from the nasal 
cavity. Another factor influencing the detection rate of 
Mycoplasma species in this study could be the sample 
technique chosen for Mycoplasma detection. Johnson and 
Kass25 demonstrated that in some cats with chronic rhi-
nosinusitis, Mycoplasma species could only be detected in 
nasal biopsy samples and not in nasal flush samples. 
Therefore, the Mycoplasma prevalence in the FA/CB 
group and in the control group might have been underes-
timated with the sampling technique used in this study.
The sampling technique might have had an influence 
on the interpretation of BALF cytology samples and the 
results of Mycoplasma species detection. Only one area of 
the lungs was sampled, and the sample procedure was 
performed blind on all cats, as none of the FA/CB cats 
showed focal bronchopulmonary changes. A recent 
study showed that the differential cell count of BALF can 
significantly differ between different lung segments in 
cats.26 Therefore, the grade and type of inflammation 
might have been misinterpreted by sampling only one 
Table 3 Cytology results of bronchoalveolar lavage fluid samples of cats with feline asthma/chronic bronchitis and 
control cats
Cell type Patients Controls P
Physiological 11.8% (2/17) 42.9% (6/14) 0.097
Neutrophilic inflammation 11.8% (2/17) 0% (0/14) 0.488
Eosinophilic inflammation 35.3% (6/17) 0% (0/14) 0.021
Eosinophilic/neutrophilic inflammation 35.3% (6/17) 0% (0/14) 0.021
Low cellularity 5.9% (1/17) 21.4% (3/14) 0.304
Oropharyngeal contamination 0% (0/17) 35.7% (5/14) 0.012
Table 4 Polymerase chain reaction (PCR) and culture results for Mycoplasma species detection in nasal flush/nasal 
swabs and bronchoalveolar lavage fluid (BALF) samples of cats with feline asthma/chronic bronchitis and control cats
Patients Controls P
Nasal flush/swabs
PCR Mycoplasma species-positive 0% (0/13) 37.5% (5/14) 0.041
Culture Mycoplasma species-positive 0% (0/12) 16.7% (2/12) 0.196
BALF  
PCR Mycoplasma species-positive 35.3% (6/17) 50.0% (7/14) 0.481
Culture Mycoplasma species-positive 11.8% (2/17) 7.1% (2/14) 1.000
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segment, and inflammation might have been missed in 
some of the control cats with the sample technique used 
in this study.
M felis was detected as the only species in all 
Mycoplasma-positive samples in this study. This 
Mycoplasma species has been previously detected in cats 
with upper7,8 and lower respiratory tract disease.15 In 
this study, M felis was detected in cats with and without 
signs of respiratory tract disease, suggesting that this 
species might represent a non-pathogenic Mycoplasma 
species in the feline respiratory tract, potentially acting 
as a secondary pathogen if host defence mechanisms are 
impaired. Because M felis was the only Mycoplasma spe-
cies detected in this study, no conclusion can be drawn 
regarding the pathogenicity of other species in feline res-
piratory disease.
In contrast to the findings in past studies,6,22 this study 
revealed Mycoplasma species not only in the BALF of 
35% of cats with FA/CB, but also in 50% of sick cats 
without clinical signs of respiratory disease by PCR. The 
most likely explanation of why previous investigations 
failed to detect Mycoplasma organisms in healthy cats is 
the use of PCR as a more sensitive detection method in 
this study compared with detection by culture in older 
studies. When diagnostic tests were compared in this 
study there was no significant difference between the 
number of PCR-positive and culture-positive nasal sam-
ples. This is in agreement with results of a study compar-
ing PCR and the culture technique for Mycoplasma 
species detection in feline nasal flush and nasal biopsy 
samples, where concordance of results of both tech-
niques was demonstrated in 19/20 samples.27 In con-
trast, there were significantly more PCR-positive (13/31) 
than culture-positive (4/31) samples in BALF in this 
study. A similar finding was described in a recent study 
in which Mycoplasma species could not be cultured in 
any of 76 cats with lower airway disease, although 15.4% 
of patients were PCR-positive for the organism.15 Based 
on these results, we recommend the use of PCR rather 
than culture for the detection of Mycoplasma species in 
lower airway samples of cats to increase sensitivity.
In this study, a non-quantitative PCR method was 
used for the detection of Mycoplasma species; however, 
quantitative analysis could be helpful in assessing the 
number of Mycoplasma organisms in feline respiratory 
samples. In future studies, the use of quantitative PCR 
might help to distinguish Mycoplasma colonisation from 
Mycoplasma infection in cats, and therefore facilitate 
interpretation of a positive Mycoplasma species result in a 
patient.
The major limitation of this study is that the control 
group consisted of cats presented with various diseases 
and not healthy animals, and samples were taken post 
mortem. Although control cats did not show any respira-
tory signs on history, had an unremarkable physical 
examination of the respiratory tract, and no signs of res-
piratory disease on BALF cytology and routine bacterial 
culture, in these systemically ill cats primary respiratory 
disease or secondary involvement of the respiratory 
tract could not be totally excluded by the diagnostic tests 
performed. It would have been helpful if thoracic imag-
ing or post-mortem examination and histopathology 
had been performed in these cats; unfortunately, these 
diagnostics were not available for most cats. Furthermore, 
it is possible that systemically ill cats showed colonisa-
tion of the upper and lower respiratory tract with 
Mycoplasma organisms owing to impairment of systemic 
and local defence mechanisms, potentially leading to a 
higher number of Mycoplasma-positive cats compared to 
a healthy population. In addition, some cats in the con-
trol population were treated with immunosuppressive 
agents prior to euthanasia, potentially facilitating the 
growth of Mycoplasma species in the airways. Therefore, 
results obtained from this population of sick cats proba-
bly do not represent the Mycoplasma status in healthy 
cats, which were not chosen as a control group because 
of ethical considerations. In addition, information about 
antibiotic treatment prior to sampling was not available 
for most cats, and antibiotic therapy was not elected as 
an exclusion criterion for the study population; however, 
antimicrobial therapy could have influenced the results 
and decreased the detection rates of Mycoplasma species 
by culture and PCR in both groups.
Conclusions
We were able to show that Mycoplasma species can be 
detected in the lower airways of cats with FA/CB, as 
well as in the BALF of sick cats without clinical and his-
torical signs of respiratory disease. Further studies are 
warranted to investigate the possibility that Mycoplasma 
species are commensals of the lower respiratory tract of 
cats, but there is insufficient evidence from this study to 
make this conclusion.
Acknowledgements We would like to thank the Institute 
for Infectious Diseases and Zoonoses of the Ludwig Maximil-
ian University of Munich for performing the bacterial and 
Mycoplasma species cultures.
Conflict of interest The authors do not have any potential 
conflicts of interest to declare.
Funding This research received no specific grant from any fund-
ing agency in the public, commercial or not-for-profit sectors.
References
 1 Reinero CR and Declue AE. Feline tracheobronchial dis-
ease. In: Fuentes VL, Johnson LR and Dennis S (eds). 
BSAVA manual of canine and feline cardiorespiratory 
medicine. 2nd ed. Gloucester: British Small Animal Veteri-
nary Association, 2010, pp 280–284.
Schulz et al 949
 2 Nafe LA, DeClue AE, Lee-Fowler TM, et al. Evaluation of 
biomarkers in bronchoalveolar lavage fluid for discrimi-
nation between asthma and chronic bronchitis in cats. Am 
J Vet Res 2010; 71: 583–591.
 3 Reinero CR. Advances in the understanding of pathogen-
esis, and diagnostics and therapeutics for feline allergic 
asthma. Vet J 2011; 190: 28–33.
 4 Razin S, Yogev D and Naot Y. Molecular biology and 
pathogenicity of mycoplasmas. Microbiol Mol Biol Rev 1998; 
62: 1094–1156.
 5 Tan RJS, Lim EW and Ishak B. Ecology of mycoplasmas in 
clinically healthy cats. Aust Vet J 1977; 53: 515–518.
 6 Randolph JF, Moise NS, Scarlett JM, et  al. Prevalence of 
mycoplasmal and ureaplasmal recovery from tracheo-
bronchial lavages and of mycoplasmal recovery from 
pharyngeal swab specimens in cats with or without pul-
monary disease. Am J Vet Res 1993; 54: 897–900.
 7 Bannasch MJ and Foley JE. Epidemiological evaluation of 
multiple respiratory pathogens in cats in animal shelters. 
J Feline Med Surg 2005; 7: 109–119.
 8 Johnson LR, Foley JE, DeCock HEV, et al. Assessment of 
infectious organisms associated with chronic rhinosinus-
itis in cats. J Am Vet Med Assoc 2005; 227: 579–585.
 9 Hartmann AD, Hawley J, Werckenthin C, et al. Detection 
of bacterial and viral organisms from the conjunctiva of 
cats with conjunctivitis and upper respiratory tract dis-
ease. J Feline Med Surg 2010; 12: 775–782.
 10 Foster SF, Barrs VR, Martin P, et al. Pneumonia associated 
with Mycoplasma spp in three cats. Aust Vet J 1998; 76: 
460–464.
 11 Chandler JC and Lappin MR. Mycoplasmal respiratory 
infections in small animals: 17 cases (1988–1999). J Am 
Anim Hosp Assoc 2002; 38: 111–119.
 12 Trow AV, Rozanski EA and Tidwell AS. Primary myco-
plasma pneumonia associated with reversible respiratory 
failure in a cat. J Feline Med Surg 2008; 10: 398–402.
 13 Bongrand Y, Blais MC and Alexander K. Atypical pneumo-
nia associated with a Mycoplasma isolate in a kitten. Can 
Vet J 2012; 53: 1109–1113.
 14 Foster SF, Martin P, Braddock JA, et al. A retrospective anal-
ysis of feline bronchoalveolar lavage cytology and micro-
biology (1995–2000). J Feline Med Surg 2004; 6: 189–198.
 15 Reed N, Simpson K, Ayling R, et al. Mycoplasma species in 
cats with lower airway disease: improved detection and 
species identification using a polymerase chain reaction 
assay. J Feline Med Surg 2012; 14: 833–840.
 16 MacDowell AL and Bacharier LB. Infectious triggers of 
asthma. Immunol Allergy Clin North Am 2005; 25: 45–66.
 17 Kicinski P, Wisniewska-Ligier M and Wozniakowska-
Gesicka T. Pneumonia caused by Mycoplasma pneumoniae 
and Chlamydophila pneumoniae in children – comparative 
analysis of clinical picture. Adv Med Sci 2011; 56: 56–63.
 18 Lieberman D, Lieberman D, Printz S, et  al. Atypical 
pathogen infection in adults with acute exacerbation of 
bronchial asthma. Am J Respir Crit Care Med 2003; 167: 
406–410.
 19 Kraft M, Cassell GH, Pak, et al. Mycoplasma pneumoniae 
and Chlamydia pneumoniae in asthma: effect of clarithro-
mycin. Chest 2002; 121: 1782–1788.
 20 Esposito S, Droghetti R, Bosis S, et al. Cytokine secretion 
in children with acute Mycoplasma pneumoniae infection 
and wheeze. Pediatr Pulmonol 2002; 34: 122–127.
 21 Traversa D, Di Cesare A, Milillo P, et al. Aelurostrongylus 
abstrusus in a feline colony from central Italy: clinical fea-
tures, diagnostic procedures and molecular characteriza-
tion. Parasitol Res 2008; 103: 1191–1196.
 22 Padrid PA, Feldman BF, Funk K, et al. Cytologic, microbio-
logic, and biochemical analysis of bronchoalveolar lavage 
fluid obtained from 24 healthy cats. Am J Vet Res 1991; 52: 
1300–1307.
 23 Hawkins EC, Kennedy-Stoskopf S, Levy J, et al. Cytologic 
characterization of bronchoalveolar lavage fluid collected 
through an endotracheal tube in cats. Am J Vet Res 1994; 55: 
795–802.
 24 Moise N, Wiedenkeller D and Yeager A. Clinical, radio-
graphic, and bronchial cytologic features of cats with 
bronchial disease: 65 cases (1980–1986). J Am Vet Med Assoc 
1989; 194: 1467–1473.
 25 Johnson LR and Kass PH. Effect of sample collection 
methodology on nasal culture results in cats. J Feline Med 
Surg 2009; 11: 645–649.
 26 Ybarra WL, Johnson LR, Drazenovich TL, et  al. Interpre-
tation of multisegment bronchoalveolar lavage in cats 
(1/2001–1/2011). J Vet Intern Med 2012; 26: 1281–1287.
 27 Johnson LR, Drazenovich NL and Foley JE. A comparison 
of routine culture with polymerase chain reaction tech-
nology for the detection of Mycoplasma species in feline 
nasal samples. J Vet Diagn Invest 2004; 16: 347–351.
